CPT miscellaneous-medical-services-m0075-m0301 Reimbursement & Policy Analysis

HCPCS-M0220-TIXAGEVIMAB-CILGAVIMAB-PRE-EXPOSURE-PROPHYLAXIS

HCPCS M0220: Tixagevimab and Cilgavimab Injection for Pre-Exposure Prophylaxis

HCPCS-M0243-CASIRIVIMAB-IMDEVIMAB-INFUSION-INJECTION-MONITORING

HCPCS M0243: Casirivimab and Imdevimab Infusion or Injection

HCPCS-M0247-SOTROVIMAB-INTRAVENOUS-INFUSION-WITH-MONITORING

HCPCS M0247: Intravenous Infusion of Sotrovimab, Includes Monitoring

HCPCS-M0100-INTRAGASTRIC-HYPOTHERMIA-GASTRIC-FREEZING

HCPCS M0100: Intragastric Hypothermia Using Gastric Freezing

HCPCS-M0224-PEMIVIBART-PRE-EXPOSURE-PROPHYLAXIS-INFUSION

HCPCS M0224: Pemivibart IV Infusion for Pre-Exposure Prophylaxis

HCPCS-M0236-MONOCLONAL-ANTIBODY-INFUSION-COVID19-HOSPITALIZED-PATIENTS

HCPCS M0236: Monoclonal Antibody Infusion, Second Dose for Hospitalized COVID-19 Patients

HCPCS-M0246-BAMLANIVIMAB-ETESEVIMAB-HOME-INFUSION

HCPCS M0246: Bamlanivimab and Etesevimab IV Infusion in Home

HCPCS-M0221-TIXAGEVIMAB-CILGAVIMAB-PRE-EXPOSURE-PROPHYLAXIS-HOME-ADMINISTRATION

HCPCS M0221: Tixagevimab and Cilgavimab Pre-Exposure Prophylaxis

HCPCS-M0249-TOCILIZUMAB-INFUSION-HOSPITALIZED-COVID19-RESPIRATORY-SUPPORT

HCPCS M0249: Tocilizumab IV Infusion for Hospitalized COVID-19 Patients, First Dose

HCPCS-M0222-BEBTELOVIMAB-INTRAVENOUS-INJECTION-MONITORING

HCPCS M0222: Intravenous Injection of Bebtelovimab, Includes Monitoring